Thursday, March 6, 2014

Recent Research Study Mayo Clinic Confirms the Worse

The call is for all women to sign petition -I have initiated in Canada but should be known globally due lack of information given to patients that can directly affect their mortality.

SIGN PETITION TO SAVE YOUR LIFE & OTHER WOMEN
COPY & PASTE 
https://www.change.org/en-CA/petitions/canadian-government-to-cover-cyp2d6-blood-test-for-women-on-tamoxifen-for-breast-cancer-mandatory-cyp2d6-blood-test-for-women-on-tamoxifen-to-prevent-further-recurrences?share_id=CnJCxDzHDR&utm_campaign=mailto_link&utm_medium=email&utm_source=share_petition


Here is recent research article by Mayo http://www.medscape.com/viewarticle/776933
recent studies confirming needing this bloodwork otherwise
he new study suggests that CYP2D6 can predict ineffectiveness. The results show that after 5 years of taking tamoxifen, breast cancer patients with genetic alterations of CYP2D6 who are considered to be poor metabolizers of tamoxifen experienced disease recurrence or died at a rate that was 2.5 times higher than women with normal CYP2D6 enzyme activity.

No comments:

Post a Comment